indium (in-111) oxinat curiumpharma 37 mbq/ml stamlösning till radioaktiva läkemedel
curium netherlands b.v. - indium(in-111)oxinat - stamlösning till radioaktiva läkemedel - 37 mbq/ml - indium(in-111)oxinat 37 mbq aktiv substans - indium(in-111)oxin
indium (in-111) klorid curiumpharma 370 mbq/ml stamlösning till radioaktiva läkemedel
curium netherlands b.v. - indium(in-111)klorid - stamlösning till radioaktiva läkemedel - 370 mbq/ml - indium(in-111)klorid 370 mbq aktiv substans - diagnostiska radiofarmaka
indium(in-111)klorid ge healthcare 370 mbq/ml stamlösning till radioaktiva läkemedel
ge healthcare limited - indium(in-111)klorid - stamlösning till radioaktiva läkemedel - 370 mbq/ml - indium(in-111)klorid 370 mbq aktiv substans - indium(in-111)föreningar
indium(in-111)oxin ge healthcare 37 mbq/ml stamlösning till radioaktiva läkemedel
ge healthcare limited - indium(in-111)oxin - stamlösning till radioaktiva läkemedel - 37 mbq/ml - indium(in-111)oxin 37 mbq aktiv substans - indium(in-111)oxin
octreoscan 111 mbq/ml beredningssats för radioaktivt läkemedel
curium netherlands b.v. - indium(in-111)klorid; pentetreotid - beredningssats för radioaktivt läkemedel - 111 mbq/ml - pentetreotid 10 mikrog aktiv substans; indium(in-111)klorid 122 mbq aktiv substans - indium(in-111)pentetreotid
nexobrid
mediwound germany gmbh - proteolytic enzymes enriched in bromelain - debridering - förberedelser för behandling av sår och sår - nexobrid är indicerat för avlägsnande av eschar hos vuxna med djupa partiella och fullständiga värmebildningar.
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
comirnaty
biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. användning av detta vaccin bör ske i enlighet med officiella rekommendationer.
bemfola
gedeon richter plc. - follitropin alfa - anovulation - könshormoner och modulatorer av könsorganen, - in adult women:anovulation (including polycystic ovarian disease, pcod) in women who have been unresponsive to treatment with clomiphene citrate;stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (art) such as in vitro fertilisation (ivf), gamete intra-fallopian transfer (gift) and zygote intra-fallopian transfer (zift);follitropin alfa in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. i kliniska prövningar dessa patienter definierades av en endogen serum lh nivå < 1. 2 ie / l. in adult men:follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotrophin (hcg) therapy.
kriptazen
virbac s.a. - halofuginon - medel mot protozoer - kalvar, nyfödda - in new born calves:- prevention of diarrhoea due to diagnosed cryptosporidium parvum, in farms with history of cryptosporidiosis,administration should start in the first 24 to 48 hours of age- reduction of diarrhoea due to diagnosed cryptosporidium parvum. administrering bör inledas inom 24 timmar efter uppkomsten av diarré. i båda fallen har minskningen av oocyter utsöndring visats.